GlassScriptPhysician profile
Farid F Zayed
NPI 1417913690
$37,578.20
in general payments reported to CMS, 2019-2025
28 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2021: $467 · 2022: $26K · 2023: $1,404 · 2024: $9,125 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $8,769 · Food and Beverage: $1,925 · Travel and Lodging: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $8,768.71 |
| Food and Beverage | $1,924.78 |
| Travel and Lodging | $319.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $32,352.04 | 2022-2024 | Angiodynamics, Auryon Atherectomy Catheter 1.5 Mm Otw |
| Medtronic, INC. | $2,224.77 | 2022-2025 | Ellipsys Vascular Access System, Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $720.77 | 2021-2024 | Cardiomems, Mitraclip, Jot Dx |
| Boston Scientific Corporation | $288.59 | 2023-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $222.73 | 2022-2024 | Lokelma, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.01 | 2021-2025 | Lifevest |
| Daiichi Sankyo INC. | $164.75 | 2021-2023 | Injectafer |
| Atricure, INC. | $146.05 | 2025 | Synergy Ablation System |
| Merck Sharp & Dohme LLC | $132.07 | 2021-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $129.55 | 2021-2024 | Camzyos |
| Bard Peripheral Vascular, INC. | $125.71 | 2022 | |
| Pfizer INC. | $121.91 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $112.56 | 2022 | |
| Inari Medical, INC. | $96.75 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $83.47 | 2021-2023 | Repatha |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $70.49 | 2021-2022 | |
| Esperion Therapeutics, INC. | $47.49 | 2021-2022 | |
| Medtronic Vascular, INC. | $45.02 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.29 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.01 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $34.15 | 2022-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $31.31 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $27.04 | 2022-2023 | Assure Wcd |
| Biotronik INC. | $26.72 | 2022 | |
| Edwards Lifesciences Corporation | $25.36 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $25.05 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $23.74 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farid Zayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.